Detalhe da pesquisa
1.
Adjuvant chemotherapy in older women with early-stage breast cancer.
N Engl J Med
; 360(20): 2055-65, 2009 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-19439741
2.
Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial.
J Clin Oncol
; 37(26): 2338-2348, 2019 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31339827
3.
A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
Clin Cancer Res
; 13(2 Pt 1): 515-22, 2007 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17255273
4.
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Clin Cancer Res
; 11(23): 8418-24, 2005 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16322304
5.
Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment.
Int J Oncol
; 25(6): 1677-83, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15547705
6.
A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer.
Lung Cancer
; 39(2): 191-6, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12581572
7.
Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study.
Lung Cancer
; 38(1): 65-71, 2002 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12367795
8.
Phase I study of dose-dense alternating doublets in advanced non-small-cell lung cancer.
Clin Lung Cancer
; 3(4): 265-70, 2002 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-14662035
9.
The role of cooperative groups in cancer clinical trials.
Cancer Treat Res
; 132: 111-29, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17305018
10.
Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction.
Med Oncol
; 28 Suppl 1: S152-61, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20730572
11.
A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer.
Cancer
; 115(8): 1713-22, 2009 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19208430
12.
Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430.
J Thorac Oncol
; 3(11): 1301-7, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18978566
13.
A phase II study of ABT-751 in patients with advanced non-small cell lung cancer.
J Thorac Oncol
; 3(6): 631-6, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18520803
14.
Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
J Thorac Oncol
; 3(1): 59-67, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18166842
15.
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.
J Clin Oncol
; 26(6): 848-55, 2008 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18281656
16.
Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.
J Thorac Oncol
; 3(9): 1003-11, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18758303
17.
The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinib.
J Thorac Oncol
; 2(5): 414-22, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17473657
18.
Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer.
J Thorac Oncol
; 1(3): 245-51, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17409864
19.
A phase II trial of UFT and leucovorin in women 65 years and older with advanced breast cancer.
Am J Clin Oncol
; 28(1): 65-9, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15685037
20.
Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors.
Invest New Drugs
; 22(4): 449-58, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15292715